IDO1 and neoplasm: Since, IDO+ CD25+ DCreg are present in the tumor microenvironment one could postulate that these regulatory cells—similar to other myeloid cells with inhibitory functions are part of the immune deviation from activation to inhibition in the tumor microenvironment.